<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Exicure, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of immunomodulatory and gene regulating drugs against validated targets. Exicure's proprietary 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of therapeutic oligonucleotides in a wide range of cells and tissues. Exicure's lead programs address oncology, inflammatory diseases and genetic disorders. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      David A. Giljohann
    • FOUNDED
      2009
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Heron Therapeutics, Inc.

    Heron Therapeutics, Inc.

    Our mission is to improve the lives of patients by developing novel, best-in-class...

    Our mission is to improve the lives of patients...

    Filing Type:    PU
    Phenomix Sciences LLC

    Phenomix Sciences LLC

    The objective of Phenomix Sciences, LLC (Phenomix) is to provide healthcare soluti...

    The objective of Phenomix Sciences, LLC (Phenom...

    Amount Raised:    $288,547.00
    Fundraising Status:    EC
    Filing Type:    CF
    Avinger, Inc.

    Avinger, Inc.

    Avinger is a commercial-stage medical device company that designs, manufactures an...

    Avinger is a commercial-stage medical device co...

    Filing Type:    PU
    BioMarin Pharmaceutical Inc.

    BioMarin Pharmaceutical Inc.

    At BioMarin, we focus on developing first-in-class and best-in-class therapeutics ...

    At BioMarin, we focus on developing first-in-cl...

    Filing Type:    PU
    Summit Therapeutics plc

    Summit Therapeutics plc

    Summit Therapeutics is a leader in antibiotic innovation. Our new mechanism antibi...

    Summit Therapeutics is a leader in antibiotic i...

    Filing Type:    PU
    Puma Biotechnology Inc

    Puma Biotechnology Inc

    Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the develo...

    Puma Biotechnology, Inc. is a biopharmaceutical...

    Filing Type:    PU
    ProLung, Inc.

    ProLung, Inc.

    ProLung is a medical technology company specializing in innovative predictive anal...

    ProLung is a medical technology company special...

    Filing Type:    PU
    NuCana plc

    NuCana plc

    We are a clinical-stage biopharmaceutical company focused on significantly improvi...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    Exact Sciences Corporation

    Exact Sciences Corporation

    Exact Sciences Corp. (NASDAQ: EXAS) is committed to playing a role in the eradicat...

    Exact Sciences Corp. (NASDAQ: EXAS) is committe...

    Filing Type:    PU
    Arena Pharmaceuticals, Inc.

    Arena Pharmaceuticals, Inc.

    Arena Pharmaceuticals is driven to deliver novel, transformational medicines with ...

    Arena Pharmaceuticals is driven to deliver nove...

    Filing Type:    PU
    Akari Therapeutics Plc

    Akari Therapeutics Plc

    Akari is a biopharmaceutical company focused on developing inhibitors of acute and...

    Akari is a biopharmaceutical company focused on...

    Filing Type:    PU
    Viela Bio, Inc.

    Viela Bio, Inc.

    Viela is dedicated to the development and commercialization of novel, life-changin...

    Viela is dedicated to the development and comme...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.